unless there way of positive EBITDA is stop spending for international clearances then they would be right but there goes any chance at growth for gss
Ann: Decision to Cease Development of US Respiratory Product, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.90M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 36.5¢ | $17.31K | 47.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3407 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 9000 | 1 |
View Market Depth
| Last trade - 12.34pm 14/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |